ArticleScientific data2026
A Multi-center Gadolinium-ethoxybenzyl-diethylenetriamine Pentaacetic Acid (Gd-EOB-DTPA) MRI Dataset with Expert Annotations and clinicopathological data.
Article in Scientific data, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Liver resection is a cornerstone treatment for liver tumors, yet post-hepatectomy liver failure (PHLF) remains a severe and life-threatening complication with no effective treatment. Recent advances in artificial intelligence (AI) have shown promise in addressing this challenge; however, progress has been hindered by the limited availability of high-quality, expert-annotated, multi-center datasets. To bridge this critical gap, we present a multi-institutional dataset of preoperative Gd-EOB-DTPA-enhanced MRI scans, comprising 14,895 images from 220 patients across three academic medical centers. This comprehensive dataset includes 22,342 expert annotations of key anatomical structures (i.e., liver, Couinaud segments, liver tumors, spleen, and psoas muscle), detailed clinicopathological variables, and rigorously adjudicated PHLF outcomes. We also release U-Net-based automated segmentation tools to support reproducible region-of-interest delineation. Furthermore, we provide an illustrative (non-validated) pipeline demonstrating how FLR volumetry, MRI-derived functional parameters, and clinical risk factors can be integrated to support downstream analysis and methodological development. The described pipeline is illustrative and does not represent a validated predictive model. This dataset aims to facilitate research in FLR assessment and PHLF prediction, providing a resource for research on preoperative assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.